Sexually Transmitted Infections Treatment Guidelines, 2021
Open accessThe DOI matches its Crossref record; 1,459 of the 1,505 references it cites were found in a registry or an index; 371 of the 802 sources its claims cite were checked for support.
Abstract
These guidelines for the treatment of persons who have or are at risk for sexually transmitted infections (STIs) were updated by CDC after consultation with professionals knowledgeable in the field of STIs who met in Atlanta, Georgia, June 11-14, 2019. The information in this report updates the 2015 guidelines. These guidelines discuss 1) updated recommendations for treatment of Neisseria gonorrhoeae, Chlamydia trachomatis, and Trichomonas vaginalis; 2) addition of metronidazole to the recommended treatment regimen for pelvic inflammatory disease; 3) alternative treatment options for bacterial vaginosis; 4) management of Mycoplasma genitalium; 5) human papillomavirus vaccine recommendations and counseling messages; 6) expanded risk factors for syphilis testing among pregnant women; 7) one-time testing for hepatitis C infection; 8) evaluation of men who have sex with men after sexual assault; and 9) two-step testing for serologic diagnosis of genital herpes simplex virus. Physicians and other health care providers can use these guidelines to assist in prevention and treatment of STIs.
Overview
CoChat Summary
TL;DR
These CDC guidelines update the 2015 STI treatment recommendations after expert consultation and systematic literature review, covering prevention, diagnosis, treatment, and special populations. They include updated guidance for gonorrhea, chlamydia, trichomoniasis, pelvic inflammatory disease, bacterial vaginosis, *Mycoplasma genitalium*, HPV vaccination, syphilis screening in pregnancy, hepatitis C testing, sexual assault evaluation, and HSV serology.
Key findings
- Congenital syphilis in the United States increased from 8.4 to 48.5 cases per 100,000 births during 2012–2019, a 477.4% increase.
- Three randomized controlled trials in sub-Saharan Africa found male circumcision reduced HIV acquisition among men by 50%–60%; HPTN 052 found ART for the infected partner decreased HIV transmission to uninfected heterosexual partners by 96%.
- Doxycycline postexposure prophylaxis after unprotected anal sex among MSM and transgender women reduced incident chlamydia and syphilis by 70% and 73%, respectively, but had no effect on gonorrhea.
- Expedited partner therapy trials showed reductions in chlamydia prevalence at follow-up of approximately 20% and gonorrhea of approximately 50%.
Methods
- CDC staff worked with subject matter experts to identify key questions and conduct systematic MEDLINE-based literature reviews for each section of the 2015 guidelines, focused on microbiologic eradication, symptom alleviation, prevention of sequelae, and prevention of transmission.
- Experts presented literature assessments at an in-person meeting in Atlanta, Georgia, June 11–14, 2019; evidence was rated high, medium, or low using USPSTF-style ratings, and draft recommendations underwent peer review and a public webinar before finalization.
- Recommendations for HIV, hepatitis C, cervical cancer screening, STI screening in pregnancy, HPV testing, and HAV/HBV vaccination were developed after reviewing existing published recommendations.
Limitations
- The paper states these guidelines are “a source of clinical guidance rather than prescriptive standards” and that providers should consider each person’s clinical circumstances and local disease prevalence.
- The paper states several evidence gaps, including limited data on doxycycline STI prophylaxis, no long-term data on STI postexposure prophylaxis effects on antimicrobial resistance and the microbiome, and insufficient data to recommend routine anal cancer screening with anal cytology.
- Evident from the text: many recommendations, especially for syphilis treatment, rely on decades of clinical experience and observational data rather than randomized controlled trials; the document is a broad guideline rather than a single primary study with a defined sample or comparator.
Model-written summary of a shortened version of the paper’s full text (it is longer than we read). Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
221 Valid · 41 Not valid · 158 Not checked · 82 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“Adherence can be low (48), and prevention of HIV infection, especially among women, has not been demonstrated (47,49).”
§ Sexually Transmitted Infections Treatment Guidelines, 2021 > Clinical Prevention Guidance > Primary Prevention Methods
What the sources say
- Disputedcites [47] Abdool Karim Q, Abdool Karim SS, Frohlich JA,; CAPRISA 004 Trial Group. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science 2010; 329: 1168– 74. Erratum in: Science 2011;333:524. 10.1126/science.1193748 20643915 PMC3001187 sourceExperimental — accuracy not yet measured
The Results (‘HIV incidence and effectiveness’; page unavailable) report 5.6 HIV infections per 100 women-years with tenofovir gel versus 9.1 with placebo (p=0.017) in a trial of women. The Discussion states that the gel reduced HIV infection by an estimated 39%. Although the authors call for corroboration, their findings directly contradict the claim that prevention had not been demonstrated. (LLM, conf=0.91)
Checked by a reasoning model — may be wrong.
- Not checked — no full text of the sourcecites [49] Delany-Moretlwe S, Lombard C, Baron D, Tenofovir 1% vaginal gel for prevention of HIV-1 infection in women in South Africa (FACTS-001): a phase 3, randomised, double-blind, placebo-controlled trial. Lancet Infect Dis 2018; 18: 1241– 50. 10.1016/S1473-3099(18)30428-6 30507409 source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“In addition, nontreponemal test titers might decrease more slowly for persons previously treated for syphilis (594,595).”
§ Sexually Transmitted Infections Treatment Guidelines, 2021 > Syphilis > Primary and Secondary Syphilis
What the sources say
- Could not verifycites [594] Ghanem KG, Erbelding EJ, Wiener ZS, Rompalo AM. Serological response to syphilis treatment in HIV-positive and HIV-negative patients attending sexually transmitted diseases clinics. Sex Transm Infect 2007; 83: 97– 101. 10.1136/sti.2006.021402 16943224 PMC2598600 sourceExperimental — accuracy not yet measured
The Results (page unavailable) mention a history of syphilis infection, but do not compare titre declines by prior treatment history. The paper compares response times by HIV status and syphilis stage; searches for prior treatment and serological response found no passage addressing whether previously treated patients’ titres decline more slowly. (LLM, conf=0.76)
- Disputedcites [595] Seña AC, Wolff M, Martin DH, Predictors of serological cure and serofast state after treatment in HIV-negative persons with early syphilis. Clin Infect Dis 2011; 53: 1092– 9. 10.1093/cid/cir671 21998287 PMC3205200 sourceExperimental — accuracy not yet measured
In Characteristics Associated With Serological Cure (page unavailable), the paper reports that a history of syphilis was not significantly associated with serological cure; the Discussion likewise says it found no association between history of syphilis and serological response. It mentions a prior study finding less seroreversion after repeat infection, but that is not a finding that titers decrease more slowly in previously treated persons. (LLM, conf=0.82)
Checked by a reasoning model — may be wrong.
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“Available data demonstrate that use of additional doses of benzathine penicillin G, amoxicillin, or other antibiotics do not enhance efficacy of this recommended regimen when used to treat primary and secondary syphilis, regardless of HIV status (591–593).”
§ Sexually Transmitted Infections Treatment Guidelines, 2021 > Syphilis > Primary and Secondary Syphilis
What the sources say
- Not checked — no full text of the sourcecites [591] Rolfs RT, Joesoef MR, Hendershot EF,; The Syphilis and HIV Study Group. A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. N Engl J Med 1997; 337: 307– 14. 10.1056/NEJM199707313370504 9235493 source
- Disputedcites [592] Yang CJ, Lee NY, Chen TC, One dose versus three weekly doses of benzathine penicillin G for patients co-infected with HIV and early syphilis: a multicenter, prospective observational study. PLoS One 2014; 9: e109667. 10.1371/journal.pone.0109667 25286091 PMC4186862 sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) explicitly says that, among HIV-infected patients with early syphilis, one dose of benzathine penicillin G was inferior to three weekly doses for serological response at 12 months—the opposite of the claim about additional doses. The study excluded patients who received other antibiotics, so it does not establish whether adding amoxicillin or other antibiotics helps; it also does not establish the claim regardless of HIV status. (LLM, conf=0.90)
Checked by a reasoning model — may be wrong.
- Partly supportedcites [593] Ganesan A, Mesner O, Okulicz JF,; Infectious Disease Clinical Research Program HIV/STI Working Group. A single dose of benzathine penicillin G is as effective as multiple doses of benzathine penicillin G for the treatment of HIV-infected persons with early syphilis. Clin Infect Dis 2015; 60: 653– 60. 10.1093/cid/ciu888 25389249 PMC6477935 sourceExperimental — accuracy not yet measured
The Factors Associated With Treatment Response section reports similar responses with one versus multiple BPG doses in HIV-infected people with early syphilis. The study does not establish that adding amoxicillin or other antibiotics to the recommended regimen offers no benefit: its “other” regimens were grouped together and could be alternatives rather than additions. Nor do its findings establish the result regardless of HIV status; the Discussion also notes limited power for people with advanced immunosuppression. Page numbers were not available in our copy. (LLM, conf=0.89)
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“Available data demonstrate that additional doses of benzathine penicillin G, amoxicillin, or other antibiotics in early latent syphilis do not enhance efficacy, regardless of HIV status (592,593,609).”
§ Sexually Transmitted Infections Treatment Guidelines, 2021 > Syphilis > Latent Syphilis
What the sources say
- Disputedcites [592] Yang CJ, Lee NY, Chen TC, One dose versus three weekly doses of benzathine penicillin G for patients co-infected with HIV and early syphilis: a multicenter, prospective observational study. PLoS One 2014; 9: e109667. 10.1371/journal.pone.0109667 25286091 PMC4186862 sourceExperimental — accuracy not yet measured
The Results report that three weekly doses of benzathine penicillin G were associated with a higher serological response than one dose in patients with HIV and early syphilis; the Discussion explicitly calls the one-dose regimen inferior at 12 months. This contradicts the claim that additional doses do not enhance efficacy. The study did not test additional amoxicillin or other antibiotics, or patients without HIV. (LLM, conf=0.90)
Checked by a reasoning model — may be wrong.
- Partly supportedcites [593] Ganesan A, Mesner O, Okulicz JF,; Infectious Disease Clinical Research Program HIV/STI Working Group. A single dose of benzathine penicillin G is as effective as multiple doses of benzathine penicillin G for the treatment of HIV-infected persons with early syphilis. Clin Infect Dis 2015; 60: 653– 60. 10.1093/cid/ciu888 25389249 PMC6477935 sourceExperimental — accuracy not yet measured
The Results report similar treatment responses with one versus multiple BPG doses in HIV-infected people with early syphilis. However, the Data Analysis and Definitions section says syphilis stage was not consistently captured, and the study did not establish the claim specifically for early latent syphilis, amoxicillin or other added antibiotics, or people without HIV. The Discussion further limits its conclusion to patients with preserved CD4 counts and low viral loads. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [609] Rolfs RT, Joesoef MR, Hendershot EF,; The Syphilis and HIV Study Group. A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. N Engl J Med 1997; 337: 307– 14. 10.1056/NEJM199707313370504 9235493 source
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“Available data demonstrate that additional doses of benzathine penicillin G, amoxicillin, or other antibiotics in primary and secondary syphilis among persons with HIV infection do not result in enhanced efficacy (592,593,609).”
§ Sexually Transmitted Infections Treatment Guidelines, 2021 > Syphilis > Syphilis Among Persons with HIV Infection
What the sources say
- Disputedcites [592] Yang CJ, Lee NY, Chen TC, One dose versus three weekly doses of benzathine penicillin G for patients co-infected with HIV and early syphilis: a multicenter, prospective observational study. PLoS One 2014; 9: e109667. 10.1371/journal.pone.0109667 25286091 PMC4186862 sourceExperimental — accuracy not yet measured
The Results report that three weekly doses of benzathine penicillin G were independently associated with a higher serological response than one dose in HIV-infected patients with early syphilis. The Discussion says the subgroup results generally favored three doses, except among patients presenting with primary syphilis; the study did not test additional amoxicillin or other antibiotics. These findings contradict the cited sentence’s blanket claim of no enhanced efficacy. (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
- Partly supportedcites [593] Ganesan A, Mesner O, Okulicz JF,; Infectious Disease Clinical Research Program HIV/STI Working Group. A single dose of benzathine penicillin G is as effective as multiple doses of benzathine penicillin G for the treatment of HIV-infected persons with early syphilis. Clin Infect Dis 2015; 60: 653– 60. 10.1093/cid/ciu888 25389249 PMC6477935 sourceExperimental — accuracy not yet measured
The Results (Factors Associated With Treatment Response; page not provided) found similar serologic responses with one versus multiple BPG doses in HIV-infected people with early syphilis. It also found no improved response for a pooled “other” regimen group, but the Data Analysis and Definitions section says that group combined penicillin derivatives used alone or with BPG and non-penicillin antibiotics. The paper therefore does not establish the claim specifically for additional amoxicillin or each other antibiotic. (LLM, conf=0.83)
- Not checked — no full text of the sourcecites [609] Rolfs RT, Joesoef MR, Hendershot EF,; The Syphilis and HIV Study Group. A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. N Engl J Med 1997; 337: 307– 14. 10.1056/NEJM199707313370504 9235493 source
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
264 more claims · 126 with their cited sources checked
Create a free account to see all 502 claims and to verify the 10 references still open.
- Probably not a substantial claim. 72
- It may state two separate claims as one. 188
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“and a reduction of half the risk of perinatal death (RR, 0.50; 95% CI: 0.33-0.84) (5) as long as treatment for GS been administered 30 days before delivery 5.”
From Efectividad del tratamiento de la sífilis gestacional en el último trimestre sobre la incidencia de sífilis congénita: revisión sistemática y metanálisis (2025) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The strategy of early diagnosis with rapid tests and immediate treatment (on the same day) with at least one dose of benzathine penicillin leads to a reduction of about 98% in the incidence of CS (relative risk (RR), 0.02; 95% confidence interval (CI: 0.00-0.18)”
From Efectividad del tratamiento de la sífilis gestacional en el último trimestre sobre la incidencia de sífilis congénita: revisión sistemática y metanálisis (2025) · cites this paper as [5]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Sexually Transmitted Infections Treatment Guidelines, 2021 > Syphilis > Congenital Syphilis
“a serum quantitative nontreponemal serologic titer that is fourfold§ (or greater) higher than the mother’s titer at delivery (e.g., maternal titer = 1:2, neonatal titer ≥1:8 or maternal titer = 1:8, neonatal titer ≥1:32)¶;”
§ Sexually Transmitted Infections Treatment Guidelines, 2021 > Syphilis > Congenital Syphilis
“a serum quantitative nontreponemal serologic titer equal to or less than fourfold of the maternal titer at delivery (e.g., maternal titer = 1:8, neonatal titer ≤1:16)”
Citations
Cites
Items 1,001–1,200 of 1,461
Pol, B. J. V. D., Warren, T. J., Taylor, S. N., et al. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.01685-12 · Cited by 41
Trends in Internet use among men who have sex with men in the United States.
Paz-Bailey, G., Hoots, B. E., Xia, M., Finlayson, T., Prejean, J., Purcell, D. W., & for the NHBS Study Group (2017) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001404 · Cited by 41
Mustanski, B., Feinstein, B. A., Madkins, K., Sullivan, P., & Swann, G. (2017) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000636 · Cited by 41
The Cost-Effectiveness of Screening Men for Chlamydia trachomatis: A Review of the Literature
Gift, T. L., Blake, D. R., Gaydos, C. A., et al. (2008) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e3181723dba · Cited by 41
Sexual identity, partner gender, and sexual health among adolescent girls in the United States.
Riskind, R. G., Tornello, S. L., Younger, B. C., & Patterson, C. J. (2014) · American Journal of Public Health · doi:10.2105/ajph.2014.302037 · Cited by 41
Shedding of hepatitis C virus in semen of human immunodeficiency virus-infected men.
Turner, S. S., Gianella, S., Yip, M. J.-S., van Seggelen, W. O., Gillies, R. D., Foster, A. L., Barbati, Z. R., Smith, D. M., & Fierer, D. S. (2016) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofw057 · Cited by 41
Du Mont, J., Myhr, T. L., Husson, H., Macdonald, S., Rachlis, A., & Loutfy, M. R. (2008) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e3181824f3c · Cited by 41
Kerani, R. P., Fleming, M., DeYoung, B., & Golden, M. R. (2011) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e318223fcbc · Cited by 41
Gaydos, C. A., Schwebke, J. R., Dombrowski, J., Marrazzo, J. M., Coleman, J. S., Silver, B., Barnes, M., Crane, L., & Fine, P. M. (2017) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2017.1282823 · Cited by 40
McClung, N. M., Lewis, R. M., Gargano, J. W., Querec, T., Unger, E. R., & Markowitz, L. E. (2019) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2019.07.003 · Cited by 40
Chow, E. P. F., Williamson, D. A., Fortune, R., et al. (2019) · Sexually Transmitted Infections · doi:10.1136/sextrans-2018-053957 · Cited by 40
Bristow, C. C., Klausner, J. D., & Tran, A. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa350 · Cited by 40
Joesoef, M. R., Weinstock, H. S., Kent, C. K., Chow, J. M., Boudov, M. R., Parvez, F. M., Cox, T., Lincoln, T., Miller, J. L., & Sternberg, M. (2009) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e31815d6de8 · Cited by 40
Taylor, S. N., DiCarlo, R. P., & Martin, D. H. (2011) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e318225f7c2 · Cited by 40
Value of follow-up examinations of children and adolescents evaluated for sexual abuse and assault.
Gavril, A. R., Kellogg, N. D., & Nair, P. (2012) · PEDIATRICS · doi:10.1542/peds.2011-0804 · Cited by 40
Pitt, R., Fifer, H., Woodford, N., & Alexander, S. (2017) · Sexually Transmitted Infections · doi:10.1136/sextrans-2017-053164 · Cited by 40
Heystek, M., & Ross, J. D. C. (2009) · International Journal of STD & AIDS · doi:10.1258/ijsa.2008.008495 · Cited by 40
Otosyphilis: A diagnostic and therapeutic dilemma
Gleich, L. L., Linstrom, C. J., & Kimmelman, C. P. (1992) · The Laryngoscope · doi:10.1288/00005537-199211000-00010 · Cited by 40
Adolescent women can perform a point-of-care test for trichomoniasis as accurately as clinicians
Huppert, J. S., Hesse, E., Kim, G. M., et al. (2010) · Sexually Transmitted Infections · doi:10.1136/sti.2009.042168 · Cited by 40
Lo, Y.-C., Ji, D.-D., & Hung, C.-C. (2014) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0003222 · Cited by 40
Pallawela, S. N. S., Sullivan, A. K., Macdonald, N., French, P., White, J., Dean, G., Smith, A., Winter, A. J., Mandalia, S., Alexander, S., et al. (2014) · Sexually Transmitted Infections · doi:10.1136/sextrans-2013-051401 · Cited by 39
Forsyth, S., Penney, P., & Rooney, G. (2011) · International Journal of STD & AIDS · doi:10.1258/ijsa.2009.009191 · Cited by 39
Aboud, S., Hoffman, I., Read, J., VALENTINE, M. E., Goldenberg, R., & Stringer, E. (2010) · PubMed · doi:10.17615/rj1k-d593 · Cited by 39
Miyai, T., Turner, K. R., Kent, C. K., & Klausner, J. D. (2004) · Sexually Transmitted Diseases · doi:10.1097/01.olq.0000137901.71284.6b · Cited by 39
Incidence and risk factors for verrucae in women
Dolev, J. C., Maurer, T. A., Springer, G., et al. (2008) · AIDS · doi:10.1097/qad.0b013e3283021aa3 · Cited by 39
David, M., Rumelt, S., & Weintraub, Z. (2011) · Ophthalmology · doi:10.1016/j.ophtha.2010.12.003 · Cited by 39
Petrosky, E. Y., Liu, G., Hariri, S., et al. (2016) · Clinical Pediatrics · doi:10.1177/0009922816660541 · Cited by 39
Katz, D. A., Dombrowski, J. C., Barry, M. P., Spellman, D., Bell, T. R., & Golden, M. R. (2019) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001952 · Cited by 39
Zhang, R.-L., Wang, Q.-Q., Zhang, J.-P., & Yang, L.-J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0175477 · Cited by 39
Khatib, N., Bradbury, C., Chalker, V. J., Koh, G. C. K. W., Smit, E., Wilson, S., & Watson, J. (2014) · International Journal of STD & AIDS · doi:10.1177/0956462414539464 · Cited by 38
Tsai, C. S., Shepherd, B. E., & Vermund, S. H. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2008.06.026 · Cited by 38
Turner, A. N., Reese, P. C., Fields, K. S., Anderson, J., Ervin, M., Davis, J. A., Fichorova, R. N., Roberts, M. W., Klebanoff, M. A., & Jackson, R. D. (2014) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2014.06.023 · Cited by 38
Pathela, P., Hennessy, R. R., Blank, S., Parvez, F., Franklin, W., & Schillinger, J. A. (2009) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e31815615bb · Cited by 38
Logie, C. H., Navia, D., & Loutfy, M. R. (2015) · Sexually Transmitted Infections · doi:10.1136/sextrans-2014-051745 · Cited by 38
Gonococcal infection of the neovagina in a male-to-female transsexual.
BODSWORTH, N. J., PRICE, R., & DAVIES, S. C. (1994) · Sexually Transmitted Diseases · doi:10.1097/00007435-199407000-00005 · Cited by 38
Ford, N., Venter, F., Irvine, C., Beanland, R. L., & Shubber, Z. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ093 · Cited by 38
Kristiansen, G. Q., Lisby, J. G., & Schønning, K. (2016) · Journal of Clinical Microbiology · doi:10.1128/jcm.00012-16 · Cited by 38
Ameli, N., Bacchetti, P., Morrow, R. A., Hessol, N. A., Wilkin, T. J., Young, M., Cohen, M. H., MINKOFF, H. L., Gange, S. J., & Greenblatt, R. M. (2006) · AIDS · doi:10.1097/01.aids.0000222078.75867.77 · Cited by 38
Tordoff, D. M., Morgan, J., Dombrowski, J. C., Golden, M. R., & Barbee, L. A. (2019) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000952 · Cited by 38
Garg, S., Taylor, L. E., Grasso, C., & Mayer, K. H. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit054 · Cited by 38
Effect of Trichomoniasis Therapy on Genital HIV Viral Burden Among African Women
Anderson, B., Firnhaber, C. S., Liu, T., Swarts, A., Siminya, M., Ingersoll, J., Caliendo, A. M., & Cu‐Uvin, S. (2012) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e31825725ad · Cited by 38
Hariri, S., Schuler, M. S., Naleway, A. L., Daley, M. F., Weinmann, S. A., Crane, B., Newcomer, S. R., Tolsma, D., & Markowitz, L. E. (2017) · American Journal of Epidemiology · doi:10.1093/aje/kwx253 · Cited by 37
Lillis, R., Martin, D. H., & Nsuami, M. J. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy922 · Cited by 37
Müller, E. E., Mahlangu, M. P., Lewis, D. A., & Kularatne, R. S. (2019) · BMC Infectious Diseases · doi:10.1186/s12879-019-3797-6 · Cited by 37
Gondwe, T., Ness, R. B., Totten, P. A., Astete, S. G., Tang, G., Gold, M. A., Martin, D. H., & Haggerty, C. L. (2019) · Sexually Transmitted Infections · doi:10.1136/sextrans-2019-054191 · Cited by 37
Secnidazole Treatment of Bacterial Vaginosis: A Randomized Controlled Trial
Hillier, S. L., Nyirjesy, P., Waldbaum, A. S., Schwebke, J. R., Morgan, F. G., Adetoro, N., & Braun, C. J. (2017) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000002135 · Cited by 37
Prevalence of neovaginal high-risk human papillomavirus among transgender women in the Netherlands.
van der Sluis, W. B., Buncamper, M. E., Bouman, M.-B., Elfering, L., Özer, M., Bogaarts, M., Steenbergen, R. D. M., Heideman, D. A. M., & Mullender, M. G. (2016) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000476 · Cited by 37
Muzny, C. A., Austin, E. L., Harbison, H. S., & Hook, E. W. (2014) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000194 · Cited by 37
Self-citationAcceptability of chlamydia screening using self-taken vaginal swabs
Doshi, J. S., Power, J., & Allen, E. J. (2008) · International Journal of STD & AIDS · doi:10.1258/ijsa.2008.008056 · Cited by 37
Hines, J. Z., Pinsent, T. S., Rees, K. J., Vines, J., Bowen, A. B., Hurd, J., Leman, R. F., & Hedberg, K. (2016) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6531a5 · Cited by 37
Levy, I., Gefen-Halevi, S., Nissan, I., Keller, N., Pilo, S., Wieder-Finesod, A., Litchevski, V., Shasha, D., Kedem, E., & Rahav, G. (2018) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2018.08.004 · Cited by 37
Spaulding, A. C., Miller, J., Trigg, B. G., Braverman, P. K., Lincoln, T., Reams, P. N., Staples-Horne, M., Sumbry, A., Rice, D., & Satterwhite, C. L. (2013) · Sexually Transmitted Diseases · doi:10.1097/01.olq.0000431353.88464.ab · Cited by 37
Neonatal Trichomonas vaginalis infection: a case report and review of literature
Trintis, J., Epie, N., Boss, R. D., & Riedel, S. F. (2010) · International Journal of STD & AIDS · doi:10.1258/ijsa.2010.010174 · Cited by 37
Cox, C., McKenna, J. P., Watt, A. P., & Coyle, P. V. (2015) · International Journal of STD & AIDS · doi:10.1177/0956462415597620 · Cited by 37
Lockart, I., Matthews, G. V., & Danta, M. (2019) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000515 · Cited by 37
Tong, W. W. Y., Shepherd, K., Garland, S., Meagher, A., Templeton, D. J., Fairley, C. K., Jin, F., Poynten, I. M., Zaunders, J., Hillman, R. J., et al. (2015) · Journal of Infectious Diseases · doi:10.1093/infdis/jiu461 · Cited by 36
Chetcuti, N., Beltzer, N., Methy, N., Laborde, C., Velter, A., Bajos, N., & CSF Group (2013) · Journal of Sex Research · doi:10.1080/00224499.2012.657264 · Cited by 36
Has the Time Come to Systematically Test for Mycoplasma genitalium?
Manhart, L. E. (2009) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e3181b9d825 · Cited by 36
Marcus, J. L., Glidden, D. V., McMahan, V., Lama, J. R., Mayer, K. H., Liu, A., Montoya, O., Casapía, M., Hoagland, B., & Grant, R. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091513 · Cited by 36
Wingrove, I., McOwan, A., Nwokolo, N. C., et al. (2014) · Sexually Transmitted Infections · doi:10.1136/sextrans-2014-051580 · Cited by 36
First cases of Neisseria gonorrhoeae resistant to ceftriaxone in Catalonia, Spain, May 2011
Carnicer-Pont, D., Smithson, À., Fina-Homar, E., et al. (2012) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2011.11.010 · Cited by 36
Self-Reported Papanicolaou Smears and Hysterectomies Among Women in the United States
Saraiya, M., Lee, N. C., Blackman, D., Smith, M.-J., Morrow, B., & McKenna, M. A. (2001) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(01)01447-8 · Cited by 36
Keller, M. J., Huber, A. M., Espinoza, L., Serrano, M. G., Parikh, H. I., Buck, G. A., Gold, J. A. W., Wu, Y., Wang, T., & Herold, B. C. (2019) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiz203 · Cited by 36
Braam, J. F., Slotboom, B., van Marm, S., Severs, T. T., van Maarseveen, N. M., van Zwet, T., Boel, E. C. H., Berkhout, H., Hagen, F., van de Bovenkamp, J. H. B., et al. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw584 · Cited by 36
Eing, B. R., Lippelt, L., Lorentzen, E. U., et al. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.2.407-413.2002 · Cited by 36
Gumbo, F. Z., Duri, K., Kandawasvika, G. Q., et al. (2010) · Journal of Perinatology · doi:10.1038/jp.2010.31 · Cited by 36
Gottesman, T., Yossepowitch, O., Samra, Z., Rosenberg, S., & Dan, M. (2016) · International Journal of STD & AIDS · doi:10.1177/0956462416630675 · Cited by 36
de Voux, A., Kent, J. B., Macomber, K. E., et al. (2016) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6534a6 · Cited by 35
Marrazzo, J. M., Thomas, K. K., & Ringwood, K. (2011) · Sexually Transmitted Infections · doi:10.1136/sti.2011.049213 · Cited by 35
Serum-free media for isolation of Haemophilus ducreyi.
Lockett, A. E., Dance, D. A. B., Mabey, D. C. W., & Drasar, B. S. (1991) · The Lancet · doi:10.1016/0140-6736(91)90473-3 · Cited by 35
Xiao, L., Waites, K. B., Pol, B. J. V. D., Aaron, K. J., Hook, E. W., & Geisler, W. M. (2018) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000891 · Cited by 35
Ferré, V.-M., Ekouévi, D. K., Gbeasor‐Komlanvi, F. A., Collin, G., Hingrat, Q. L., Tchounga, B., Salou, M., Descamps, D., Charpentier, C., & Dagnra, A. C. (2019) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2019.04.015 · Cited by 35
RIETMEIJER, C. A. M., Hopkins, E., Geisler, W. M., Orr, D. P., & Kent, C. K. (2008) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e31816938ba · Cited by 35
State requirements for prenatal syphilis screening in the United States, 2016.
Warren, H. P., Cramer, R., Kidd, S., & Leichliter, J. S. (2018) · Maternal and Child Health Journal · doi:10.1007/s10995-018-2592-0 · Cited by 35
Mitchell, C., Manhart, L. E., Thomas, K. K., Agnew, K., & Marrazzo, J. M. (2011) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e31822e6121 · Cited by 35
Kojima, N., Park, H., Konda, K. A., Joseph Davey, D. L., Bristow, C. C., Brown, B., Leon, S. R., Vargas, S. K., Calvo, G. M., Caceres, C. F., et al. (2017) · BMC Infectious Diseases · doi:10.1186/s12879-017-2332-x · Cited by 35
Stringer, E., Read, J., Hoffman, I., Valentine, M., Aboud, S., & Goldenberg, R. (2010) · South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde · doi:10.7196/samj.3519 · Cited by 35
Spicknall, I. H., Gift, T. L., Bernstein, K. T., & Aral, S. O. (2017) · Sexually Transmitted Infections · doi:10.1136/sextrans-2016-052676 · Cited by 34
A tale of two gonorrhea epidemics: results from the STD Surveillance Network.
Newman, L. M., Dowell, D., Bernstein, K., Donnelly, J., Martins, S., Stenger, M., Stover, J., & Weinstock, H. (2012) · Public Health Reports · doi:10.1177/003335491212700308 · Cited by 34
Primary HIV infection: clinical presentation, testing, and treatment.
Henn, A., Flateau, C., & Gallien, S. (2017) · Current Infectious Disease Reports · doi:10.1007/s11908-017-0588-3 · Cited by 34
Kellogg, N. D., Melville, J. D., Lukefahr, J. L., Nienow, S. M., & Russell, E. L. (2018) · Pediatric Emergency Care · doi:10.1097/pec.0000000000001014 · Cited by 34
Gaydos, C. A., Hobbs, M. M., Marrazzo, J. M., Schwebke, J. R., Coleman, J. S., Masek, B. J., Dize, L., Jang, D., Li, J., & Chernesky, M. (2016) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000447 · Cited by 34
Recalcitrant Trichomonas Vaginalis Infections Successfully Treated With Vaginal Acidification
Aggarwal, A., & Shier, R. M. (2008) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(16)32714-1 · Cited by 34
European guideline for the management of pediculosis pubis, 2010.
Scott, G. R., & Chosidow, O. (2011) · International Journal of STD & AIDS · doi:10.1258/ijsa.2011.011114 · Cited by 34
Vodstrcil, L. A., Plummer, E. L., Fairley, C. K., Tachedjian, G., Law, M. G., Hocking, J. S., Worthington, K., Grant, M., Okoko, N., & Bradshaw, C. S. (2019) · Scientific Reports · doi:10.1038/s41598-019-39879-8 · Cited by 34
Chen, G.-J., Lin, K.-Y., Hung, C.-C., & Chang, S.-C. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix123 · Cited by 34
Muzny, C. A., Harbison, H. S., Pembleton, E. S., & Austin, E. L. (2013) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e31828caf34 · Cited by 34
Self-citationMohan, K., Hibbert, M., Rooney, G., Canvin, M., Childs, T., Jenkins, C., Simms, I., Kirwan, P., Delpech, V., Yin, Z., et al. (2018) · Sexually Transmitted Infections · doi:10.1136/sextrans-2016-052962 · Cited by 34
Gotovtseva, E. P., Kapadia, A. S., Smolensky, M. H., et al. (2008) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e31815ea8d1 · Cited by 33
Bartlett, B. L., Tyring, S. K., Fife, K. H., Gnann, J. W., Hadala, J. T., Kianifard, F., & Berber, E. (2008) · Journal of Clinical Virology · doi:10.1016/j.jcv.2008.06.004 · Cited by 33
Slifirski, J. B., Vodstrcil, L. A., Fairley, C. K., Ong, J. J., Chow, E. P. F., Chen, M. Y., Read, T. R. H., & Bradshaw, C. S. (2017) · Emerging infectious diseases · doi:10.3201/eid2311.170998 · Cited by 33
Local and systemic adverse effects to topical imiquimod due to systemic immune stimulation
Kumar, B., & Narang, T. K. (2011) · Sexually Transmitted Infections · doi:10.1136/sextrans-2011-050025 · Cited by 33
Henderson, J. T., Webber, E. M., & Bean, S. (2019) · JAMA · doi:10.1001/jama.2019.1655 · Cited by 33
Elgalib, A., Alexander, S., Tong, C. Y. W., & White, J. A. (2011) · International Journal of STD & AIDS · doi:10.1258/ijsa.2011.011134 · Cited by 33
(2008) · PubMed · Cited by 33
Romano, S. S., Jensen, J. S., Lowens, M. S., Morgan, J. L., Chambers, L. C., Robinson, T. S., Totten, P. A., Soge, O. O., Golden, M. R., & Manhart, L. E. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy843 · Cited by 33
McGregor, J., Crombleholme, W. R., Newton, E. R., et al. (1994) · Obstetrics and Gynecology · doi:10.1097/00006250-199406000-00020 · Cited by 33
D'Anna, L. H., Margolis, A. D., Warner, L., Korosteleva, O. A., O'Donnell, L., Rietmeijer, C. A., Klausner, J. D., Nomura, W., Malotte, C. K., & the Safe City Study Group (2012) · AIDS Care · doi:10.1080/09540121.2012.668285 · Cited by 33
Zimet, G. D., Rosenthal, S. L., Fortenberry, J. D., Brady, R. C., Tu, W., Wu, J., Bernstein, D. I., Stanberry, L. R., Stone, K. M., Leichliter, J. S., et al. (2004) · Sexually Transmitted Diseases · doi:10.1097/01.olq.0000143089.77493.c2 · Cited by 32
Effect of Human Immunodeficiency Virus-1 Infection on Treatment Outcome of Acute Salpingitis
Mugo, N., Kiehlbauch, J. A., Nguti, R., Meier, A. S., Gichuhi, J. W., Stamm, W. E., & Cohen, C. R. (2006) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000207597.70524.e8 · Cited by 32
Acute Sexual Assault in the Pediatric and Adolescent Population
Trotman, G. E., Young-Anderson, C., & Deye, K. P. (2015) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2015.05.001 · Cited by 32
Amoxicillin and ceftriaxone as treatment alternatives to penicillin for maternal syphilis.
Katanami, Y., Hashimoto, T., Takaya, S., Yamamoto, K., Kutsuna, S., Takeshita, N., Hayakawa, K., Kanagawa, S., & Ohmagari, N. (2017) · Emerging infectious diseases · doi:10.3201/eid2305.161936 · Cited by 32
The effectiveness and safety of two cervical cytologic techniques during pregnancy.
Stillson, T., Al, K., & Rk, E. (1997) · PubMed · Cited by 32
Neu, N., Heffernan-Vacca, S., Millery, M., Stimell, M., & Brown, J. (2007) · Sexually Transmitted Diseases · doi:10.1097/01.olq.0000225329.07765.d8 · Cited by 32
Abbai, N. S., Nyirenda, M., Naidoo, S., & Ramjee, G. (2017) · AIDS and Behavior · doi:10.1007/s10461-017-1924-1 · Cited by 32
Agyemang, E. A., Le, Q.-A., Warren, T. J., et al. (2017) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000689 · Cited by 32
Self-citationXiao, Y., Tong, M.-L., Lin, L.-R., Liu, L.-L., Gao, K., Chen, M.-J., Zhang, H.-L., Zheng, W.-H., Li, S.-L., Lin, H.-L., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-10387-x · Cited by 32
Herweijer, E., Ploner, A., & Sparén, P. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.02.097 · Cited by 32
Epidemiological Surveillance of Congenital Syphilis in Spain, 2000–2010
Ortiz-Lopez, N., Díez, M., Diaz, O., Simón, F., & Díaz, A. (2012) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31825d3152 · Cited by 32
RIETMEIJER, C. A. M., & Mettenbrink, C. J. (2011) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e3182354da3 · Cited by 32
Herpes simplex virus type 2 serological testing and psychosocial harm: a systematic review
Ross, K. M., Johnston, C., & Wald, A. (2011) · Sexually Transmitted Infections · doi:10.1136/sextrans-2011-050099 · Cited by 32
Self-citationBurgos, J., Hernández-Losa, J., Landolfi, S., Guelar, A., Dinares, M., Villar, J., Navarro, J., Ribera, E., Falcó, V., & Curran, A. (2017) · AIDS · doi:10.1097/qad.0000000000001605 · Cited by 32
(2014) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000446825.08715.98 · Cited by 32
Characteristics and Impact of Disseminated Gonococcal Infection in the “Top End” of Australia
Birrell, J. M., Gunathilake, M., Singleton, S., et al. (2019) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.19-0288 · Cited by 32
Sharapov, U. M., Bulkow, L. R., Negus, S. E., Spradling, P. R., Homan, C., Drobeniuc, J., Bruce, M., Kamili, S., Hu, D. J., & McMahon, B. J. (2012) · Hepatology · doi:10.1002/hep.25687 · Cited by 32
Rob, F., Klubalová, B., Nyčová, E., Hercogova, J. T., & Unemo, M. (2019) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2019.08.004 · Cited by 32
Association between bacterial vaginosis and partner concurrency: a longitudinal study
Kenyon, C. R., Buyze, J., Klebanoff, M. A., & Brotman, R. M. (2016) · Sexually Transmitted Infections · doi:10.1136/sextrans-2016-052652 · Cited by 32
Evaluation and management of female victims of sexual assault.
Vrees, R. A. (2017) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0000000000000390 · Cited by 31
Leeyaphan, C., Ong, J. J., Chow, E. P. F., Kong, F. Y. S., Hocking, J. S., Bissessor, M., Fairley, C. K., & Chen, M. (2016) · Emerging infectious diseases · doi:10.3201/eid2210.160986 · Cited by 31
HIV partner services are associated with timely linkage to HIV medical care
Bocour, A., Renaud, T. C., Udeagu, C.-C. N., et al. (2013) · AIDS · doi:10.1097/qad.0000000000000031 · Cited by 31
Silverberg, M. J., Leyden, W. A., Chi, A., Gregorich, S. E., Huchko, M. J., Kulasingam, S., Kuppermann, M., Seto, A., Smith‐McCune, K., & Sawaya, G. F. (2017) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000002371 · Cited by 31
Tang, E. C., Vittinghoff, E., Philip, S. S., Doblecki-Lewis, S., Bacon, O., Chege, W., Coleman, M. E., Elion, R., Buchbinder, S., Kolber, M. A., et al. (2020) · AIDS · doi:10.1097/qad.0000000000002522 · Cited by 31
Chernesky, M., Jang, D., Martín, I., Hoang, L., Naidu, P., Levett, P. N., Wylie, J., Rebbapragada, A., Ratnam, S., Smieja, M., et al. (2017) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000617 · Cited by 31
Third-Trimester Prenatal Syphilis Screening: A Cost-Effectiveness Analysis
Albright, C. M., Emerson, J. B., Werner, E. F., & Hughes, B. L. (2015) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000000997 · Cited by 31
Gatski, M., Martin, D. H., Theall, K. P., et al. (2011) · International Journal of STD & AIDS · doi:10.1258/ijsa.2010.010320 · Cited by 31
Periocular Ulcerative Dermatitis Associated with Gentamicin Ointment Prophylaxis in Newborns
Binenbaum, G., Bruno, C. J., Forbes, B. J., et al. (2010) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2009.11.060 · Cited by 31
Cost-effectiveness of opt-out chlamydia testing for high-risk young women in the U.S.
Owusu-Edusei, K., Hoover, K. W., & Gift, T. L. (2016) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2016.01.007 · Cited by 31
Mayer, K. H., Klausner, J. D., & Handsfield, H. H. (2001) · Sexually Transmitted Diseases · doi:10.1097/00007435-200108000-00008 · Cited by 31
Prevalence and correlates of Trichomonas vaginalis infection among female US federal prison inmates.
Sutcliffe, S., Newman, S. B., Hardick, A., & Gaydos, C. A. (2010) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e3181de4113 · Cited by 31
Caviness, A. C., Oelze, L. L., Saz, U., et al. (2010) · Journal of Clinical Virology · doi:10.1016/j.jcv.2010.06.006 · Cited by 31
Successful oral acyclovir desensitization.
Re, H., Wegmann, J. A., Je, H., et al. (1993) · PubMed · Cited by 30
Go big or go home: impact of screening coverage on syphilis infection dynamics.
Tuite, A., & Fisman, D. (2016) · Sexually Transmitted Infections · doi:10.1136/sextrans-2014-052001 · Cited by 30
Development of PCR assays for detection of Trichomonas vaginalis in urine specimens.
Bandea, C. I., Joseph, K., Secor, E. W., Jones, L. A., Igietseme, J. U., Sautter, R. L., Hammerschlag, M. R., Fajman, N. N., Girardet, R. G., & Black, C. M. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.03101-12 · Cited by 30
Chlamydia trachomatis infection of the neovagina in transgender women.
Radix, A. E., Harris, A. B., Belkind, U., Ting, J., & Goldstein, Z. G. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofz470 · Cited by 30
Efficacy, acceptability and cost effectiveness of four therapeutic agents for treatment of scabies.
Abdel-Raheem, T. A., Méabed, E. M. H., Nasef, G. A., Abdel Wahed, W. Y., & Rohaim, R. M. A. (2016) · Journal of Dermatological Treatment · doi:10.3109/09546634.2016.1151855 · Cited by 30
Petrina, M. A. B., Cosentino, L. A., Wiesenfeld, H. C., et al. (2019) · Anaerobe · doi:10.1016/j.anaerobe.2019.02.005 · Cited by 30
Anderson, T. P., Coughlan, E., & Werno, A. (2017) · Journal of Clinical Microbiology · doi:10.1128/jcm.01087-17 · Cited by 30
Ahrens, K. A., Anderka, M., Feldkamp, M. L., et al. (2013) · Paediatric and Perinatal Epidemiology · doi:10.1111/ppe.12064 · Cited by 30
Cornelisse, V. J., Williamson, D. A., Zhang, L., et al. (2019) · Sexually Transmitted Infections · doi:10.1136/sextrans-2018-053803 · Cited by 30
Penicillin skin testing in cardiac surgery.
Cook, D. J., Barbara, D. W., Singh, K. E., & Dearani, J. A. (2014) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2014.01.019 · Cited by 30
Chan, P. A., Crowley, C., Rose, J. S., Kershaw, T., Tributino, A., Montgomery, M. C., Almonte, A., Raifman, J., Patel, R., & Nunn, A. (2018) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000784 · Cited by 30
Self-citationBecoming Visible: Assessing the Availability of Online Sexual Health Information for Lesbians
Lindley, L. L., Friedman, D. B., & Struble, C. B. (2011) · Health Promotion Practice · doi:10.1177/1524839910390314 · Cited by 30
Taylor, B. D., Zheng, X., O’Connell, C. M., Wiesenfeld, H. C., Hillier, S. L., & Darville, T. L. (2018) · Sexually Transmitted Infections · doi:10.1136/sextrans-2017-053376 · Cited by 30
Keeping an Eye on Chlamydia and Gonorrhea Conjunctivitis in Infants in the United States, 2010–2015
Kreisel, K. M., Weston, E. J., Braxton, J. R., et al. (2017) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000613 · Cited by 30
Bunge, K. E., Beigi, R. H., Meyn, L. A., & Hillier, S. L. (2009) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e3181af6cfd · Cited by 30
Microbiology Profile in Women With Pelvic Inflammatory Disease in Relation to IUD Use
Vīberga, I., Odlind, V., Lazdāne, G., et al. (2005) · Infectious Diseases in Obstetrics and Gynecology · doi:10.1155/2005/376830 · Cited by 30
Penicillin desensitization: Treatment of syphilis in pregnancy in penicillin-allergic patients
Pham, M. N., Ho, H.-E., & Desai, M. (2017) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2017.03.013 · Cited by 30
Faro, S., & Skokos, C. K. (2005) · Infectious Diseases in Obstetrics and Gynecology · doi:10.1080/10647440500148321 · Cited by 29
Manavi, K., Young, H. D., & Clutterbuck, D. (2003) · International Journal of STD & AIDS · doi:10.1258/095646203765371277 · Cited by 29
Cabello, A., Roblas, R. F., Delgado, R., Martínez-García, L., Sterlin, F., Guerrero, M. L. F., & Górgolas, M. (2016) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000459 · Cited by 29
High bacterial loads of Ureaplasma may be associated with non-specific cervicitis
Liu, L., Cao, G., Zhao, Z., et al. (2014) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365548.2014.922696 · Cited by 29
Price, J. C., McKinney, J. E., Crouch, P.-C., Dillon, S. M., Radix, A., Stivala, A., Carollo, J. R., & Fierer, D. S. (2019) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiy670 · Cited by 29
An Alternative Scenario to Explain Rectal Positivity in Chlamydia-Infected Individuals
Rank, R. G., & Yeruva, L. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ079 · Cited by 29
Characteristics of acute nongonococcal urethritis in men differ by sexual preference
Rane, V. S., Fairley, C. K., Weerakoon, A., Read, T. H., Fehler, G., Chen, M. Y., & Bradshaw, C. S. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.00899-14 · Cited by 29
Linhart, Y., Shohat, T., Amitai, Z., Gefen, D., Srugo, I., Blumstein, G., & Dan, M. (2008) · International Journal of STD & AIDS · doi:10.1258/ijsa.2008.008127 · Cited by 29
Bixler, D., Annambholta, P., Abara, W. E., Collier, M. G., Jones, J., Mixson-Hayden, T., Basavaraju, S. V., Ramachandran, S., Kamili, S., & Moorman, A. (2019) · American Journal of Transplantation · doi:10.1111/ajt.15352 · Cited by 29
Kapil, R., Press, C. G., Hwang, M. L., Brown, L. T., & Geisler, W. M. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.02483-14 · Cited by 29
Najafi, A., Nosrati, M. R. C., Ghasemi, E., Navi, Z., Yousefi, A., Majidiani, H., Ghaneialvar, H., Sayehmiri, K., Galván-Ramírez, M. D. L. L., & Fakhar, M. (2019) · Microbial Pathogenesis · doi:10.1016/j.micpath.2019.103752 · Cited by 29
Singh, V., Bala, M., Bhargava, A., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0193678 · Cited by 29
(2013) · PubMed · Cited by 29
Oral ivermectin for Phthirus pubis.
Burkhart, C. G., & Burkhart, C. N. (2004) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2004.04.041 · Cited by 29
Gaudreau, C., Rodrigues-Coutlée, S., Pilon, P. A., Coutlée, F., & Bekal, S. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ570 · Cited by 29
The Etiology of Male Urethral Discharge in Zimbabwe: Results from the Zimbabwe STI Etiology Study
RIETMEIJER, C. A. M., Mungati, M., Machiha, A., Mugurungi, O. M., Kupara, V., Rodgers, L., Kilmarx, P. H., Herman-Roloff, A., Gonese, E., Barr, B. A. T., et al. (2017) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000696 · Cited by 29
Day, M. J., Cole, M. J., Fifer, H., Woodford, N., & Pitt, R. (2021) · Sexually Transmitted Infections · doi:10.1136/sextrans-2020-054897 · Cited by 29
Bryan, A. D., Magnan, R. E., Gillman, A. S., Yeater, E. A., Ewing, S. W. F., Kong, A. S., & Schmiege, S. J. (2018) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/jamapediatrics.2017.5621 · Cited by 29
Crouss, T., Sobel, J. D., Smith, K., & Nyirjesy, P. (2018) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0000000000000413 · Cited by 29
van der Veer, C., van Rooijen, M. S., Himschoot, M., de Vries, H. J. C., & Bruisten, S. M. (2016) · Sexually Transmitted Infections · doi:10.1136/sextrans-2015-052118 · Cited by 28
Integrating HIV Testing as an Outcome of STD Partner Services for Men Who Have Sex with Men
Katz, D. A., Dombrowski, J. C., Kerani, R. P., Aubin, M. R., Kern, D., Heal, D. D., Bell, T. R., & Golden, M. R. (2016) · AIDS Patient Care and STDs · doi:10.1089/apc.2016.0027 · Cited by 28
Prevalence and predictors of Trichomonas infection in newly incarcerated women.
Nijhawan, A. E., Chapin, K. C., Salloway, R., Andrea, S., Champion, J., Roberts, M., & Clarke, J. G. (2012) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e31826e8847 · Cited by 28
Early diagnosis and risk factors of acute hepatitis C in high-risk MSM on preexposure prophylaxis.
Gras, J., Mahjoub, N., Charreau, I., Cotte, L., Tremblay, C., Chas, J., Raffi, F., Cua, E., Guillon, B., Guigue, N., et al. (2020) · AIDS · doi:10.1097/qad.0000000000002364 · Cited by 28
Balkus, J. E., Richardson, B. A., Mochache, V., Chohan, V., Chan, J. D., Masese, L. N., Shafi, J., Marrazzo, J. M., Farquhar, C., & McClelland, R. S. (2013) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e31828fce34 · Cited by 28
Interventions for trichomoniasis in pregnancy
Gülmezoglu, A. M. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000220 · Cited by 28
Chernesky, M., Jang, D., Portillo, E., Smieja, M., Gilchrist, J., Ewert, R., & MacRitchie, C. (2012) · Sexually Transmitted Infections · doi:10.1136/sextrans-2012-050573 · Cited by 28
Hernández-Romieu, A. C., Siegler, A. J., Sullivan, P. S., Crosby, R., & Rosenberg, E. S. (2014) · Sexually Transmitted Infections · doi:10.1136/sextrans-2014-051581 · Cited by 28
Lessons learnt from ceftriaxone-resistant gonorrhoea in the UK and Australia
Fifer, H., Hughes, G., Whiley, D. M., & Lahra, M. M. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30055-4 · Cited by 28
HIV post-exposure prophylaxis in children and adolescents presenting for reported sexual assault
Girardet, R. G., Lemme, S., Biason, T. A., Bolton, K., & Lahoti, S. L. (2009) · Child Abuse & Neglect · doi:10.1016/j.chiabu.2008.05.010 · Cited by 28
Post-exposure prophylaxis for HIV infection in sexual assault victims.
Inciarte, A., Leal, L., Masfarre, L., Gonzalez, E., Diaz‐Brito, V, Lucero, C., Garcia‐Pindado, J., León, A., García, F., & the Sexual Assault Victims Study Group (2020) · HIV Medicine · doi:10.1111/hiv.12797 · Cited by 28
Cosentino, L. A., Danby, C. S., Rabe, L. K., Macio, I. S., Meyn, L. A., Wiesenfeld, H. C., & Hillier, S. L. (2017) · Journal of Clinical Microbiology · doi:10.1128/jcm.00616-17 · Cited by 28
Gitau, R., Graham, S. M., Masese, L. N., Overbaugh, J. M., Chohan, V., Peshu, N., Richardson, B. A., Jaoko, W. G., Ndinya‐Achola, J. O., & McClelland, R. S. (2010) · AIDS · doi:10.1097/qad.0b013e32833f9f43 · Cited by 28
Dombrowski, J. C., Harrington, R. D., & Golden, M. R. (2012) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e3182753327 · Cited by 28
Napierala, M., Munson, E. L., Wenten, D., Phipps, P., Gremminger, R., Schuknecht, M. K., Munson, K. L., Boyd, V., Hamer, D., Schell, R. F., et al. (2015) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2015.03.016 · Cited by 28
Piñeiro, L., Idígoras, P., de la Caba, I., et al. (2018) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2018.10.003 · Cited by 28
Fakile, Y. F., Jost, H. A., Hoover, K. W., Gustafson, K. J., Novak-Weekley, S. M., Schapiro, J. M., Tran, A. L., Chow, J. M., & Park, I. U. (2017) · Journal of Clinical Microbiology · doi:10.1128/jcm.01165-17 · Cited by 27
Self-citationAlcaide, M. L., Feaster, D. J., Duan, R., Cohen, S. E., Diaz, C. M., Castro, J. G., Golden, M. R., Henn, S., Colfax, G. N., & Metsch, L. R. (2015) · Sexually Transmitted Infections · doi:10.1136/sextrans-2015-052010 · Cited by 27
The Immunopathogenesis of Mycoplasma genitalium Infections in Women: A Narrative Review
Mott, P. D., & McGowin, C. L. (2017) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000621 · Cited by 27
Rectal Gonorrhoea in Homosexual Men: Source of Infection
McMillan, A., Young, H.-K., & Moyes, A. (2000) · International Journal of STD & AIDS · doi:10.1177/095646240001100502 · Cited by 27
Epidemiology of Undiagnosed Trichomoniasis in a Probability Sample of Urban Young Adults
Rogers, S., Turner, C. F., Hobbs, M. M., Miller, W. C., Tan, S., Roman, A., Eggleston, E., Villarroel, M. A., Ganapathi, L., Chromy, J. R., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090548 · Cited by 27
Placental Histopathology of Congenital Syphilis
Sheffield, J. (2002) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(02)02010-0 · Cited by 27
Tomkins, A., Ahmad, S., Cousins, D. E., Thng, C. M., Vilar, F. J., & Higgins, S. P. (2018) · Sexually Transmitted Infections · doi:10.1136/sextrans-2016-052938 · Cited by 27
High-Dose Vaginal Maintenance Metronidazole for Recurrent Bacterial Vaginosis: A Pilot Study
Aguin, T., Akins, R. A., & Sobel, J. D. (2014) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000123 · Cited by 27
Tomassi, M. J., Abbas, M. A., & Klaristenfeld, D. D. (2018) · International Journal of Colorectal Disease · doi:10.1007/s00384-018-3167-7 · Cited by 27
Costumbrado, J., Stirland, A., Cox, G., Amin, A. N. E., Miranda, A., Carter, A., & Malek, M. A. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.09.006 · Cited by 27
Concentrations of metronidazole and tinidazole in male genital tissues
Viitanen, J., Haataja, H., & Männistö, P. T. (1985) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.28.6.812 · Cited by 27
Campylobacter fetus Cluster Among Men Who Have Sex With Men, Montreal, Quebec, Canada, 2014–2016
Marchand-Senécal, X., Békal, S., Pilon, P. A., Sylvestre, J.-L., & Gaudreau, C. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix610 · Cited by 27
(2016) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000001699 · Cited by 27
Chernesky, M., Freund, G. G., Hook, E. W., Leone, P. A., D’Ascoli, P., & Martens, M. G. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.00013-07 · Cited by 27
Hughes, G., Silalang, P., Were, J., Patel, H., Childs, T., Alexander, S., Duffell, S., Saxon, C., Ison, C., Mitchell, H., et al. (2018) · Sexually Transmitted Infections · doi:10.1136/sextrans-2016-053057 · Cited by 27
Glaser, A., Geisler, W. M., Ratliff, A. E., et al. (2019) · International Journal of STD & AIDS · doi:10.1177/0956462418816757 · Cited by 27
Frølund, M., Falk, L., Ahrens, P., & Jensen, J. S. (2019) · PLoS ONE · doi:10.1371/journal.pone.0214425 · Cited by 27
Anderson, C., Gallo, M. F., Hylton-Kong, T., Steiner, M. J., Hobbs, M. M., Macaluso, M., Figueroa, J. P., Jamieson, D. J., Legardy-Williams, J., Wiener, J., et al. (2013) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e31827938a1 · Cited by 27
Research works printed but not linked: 13
- Golden MR, Kerani RP, Stenger M, Effect of expedited partner therapy (EPT) on chlamydial prevalence: the Washington State Community-Level Trial. Presented at the STD Prevention Conference, Minneapolis, MN; March 12–15, 2012.
- Lin JS, Eder M, Bean S. Screening for syphilis infection in pregnant women: a reaffirmation evidence update for the U.S. Preventive Services Task Force. Evidence Synthesis No. 167. AHRQ Publication No. 18-05238-EF-1. Rockville, MD: Agency for Healthcare Research and Quality; 2018. 30234936
- Benton S, Smith J, Wang F, Heitgerd J, Belcher L, Patel H. HIV testing, diagnosis, and linkage to care among persons tested in select CDC-funded health care and non-health care settings, 2012–2017. Presented at the National HIV Prevention Conference, Atlanta, GA: March 18–21, 2019.
- Briggs GC. Drugs in pregnancy and lactation: a reference guide to fetal and neonatal risk. 11th ed. Philadelphia, PA: Wolters Kluwer; 2017.
- Blanco JL, Fuertes I, Bosch J, Effective treatment of lymphogranuloma venereum (LGV) with 1g azithormycin administered weekly for 3 weeks in HIV-infected population. Presented at the Conference on Retroviruses and Opportunist Infections, Seattle, WA; February 23–26, 2015.
- Rolfs RT, Joesoef MR, Hendershot EF,; The Syphilis and HIV Study Group. A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. N Engl J Med 1997; 337: 307– 14. 10.1056/NEJM199707313370504 9235493 · DOI · Paper page
- Ahmed KA, Fox SJ, Frigas E, Park MA. Clinical outcome in the use of cephalosporins in pediatric patients with a history of penicillin allergy. Int Arch Allergy Immunol 2012; 158: 405– 10. 10.1159/000333553 22487723 · DOI · Paper page
- Park IU, Chow JM, Bolan G, Stanley M, Shieh J, Schapiro JM. Screening for syphilis with the treponemal immunoassay: analysis of discordant serology results and implications for clinical management. J Infect Dis 2011; 204: 1297– 304. 10.1093/infdis/jir524 21930610 · DOI · Paper page
- Muzny CA, Blackburn RJ, Sinsky RJ, Austin EL, Schwebke JR. Added benefit of nucleic acid amplification testing for the diagnosis of Trichomonas vaginalis among men and women attending a sexually transmitted diseases clinic. Clin Infect Dis 2014; 59: 834– 41. 10.1093/cid/ciu446 24928292 · DOI · Paper page
- Sobel JD, Nyirjesy P, Brown W. Tinidazole therapy for metronidazole-resistant vaginal trichomoniasis. Clin Infect Dis 2001; 33: 1341– 6. 10.1086/323034 11565074 · DOI · Paper page
- Perkins RB, Guido RS, Castle PE,; 2019 ASCCP Risk-Based Management Consensus Guidelines Committee. 2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors. J Low Genit Tract Dis 2020; 24: 102– 31. 10.1097/LGT.0000000000000525 32243307 PMC7147428 · DOI · Paper page
- Al Jaff DAA, Amin MHM. Comparison of the effectiveness of sulphur ointment, permethrin and oral ivermectin in treatment of scabies. Res J Pharm Biol Chem Sci 2018; 9: 670– 6.
- Chiu S, Argaez C. Ivermectin for parasitic skin infections of scabies: a review of comparative clinical effectiveness, cost-effectiveness, and guidelines. Ottawa, ON: Canadian Agency for Drugs and Technologies in Health; 2019. https://www.ncbi.nlm.nih.gov/books/NBK545083/ 31424718
Cited by
Standards of Care for the Health of Transgender and Gender Diverse People, Version 8
Coleman, E., Radix, A. E., Bouman, W. P., Brown, G. R., de Vries, A. L. C., Deutsch, M. B., Ettner, R., Fraser, L., Goodman, M., Green, J., et al. (2022) · International Journal of Transgender Health · doi:10.1080/26895269.2022.2100644 · Cited by 2,698
Postexposure Doxycycline to Prevent Bacterial Sexually Transmitted Infections
Luetkemeyer, A. F., Donnell, D., Dombrowski, J. C., Cohen, S., Grabow, C., Brown, C. E., Malinski, C., Perkins, R., Nasser, M., Lopez, C., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2211934 · Cited by 468
Towards a deeper understanding of the vaginal microbiota
France, M., Alizadeh, M., Brown, S., Ma, B., & Ravel, J. (2022) · Nature Microbiology · doi:10.1038/s41564-022-01083-2 · Cited by 382
Miller, J. M., Binnicker, M. J., Campbell, S., Carroll, K. C., Chapin, K. C., Gonzalez, M. D., Harrington, A., Jerris, R. C., Kehl, S. C., Leal, S. M., et al. (2024) · Clinical Infectious Diseases · doi:10.1093/cid/ciae104 · Cited by 376
Diagnosis and Treatment of Sexually Transmitted Infections: A Review
Tuddenham, S., Hamill, M. M., & Ghanem, K. G. (2022) · JAMA · doi:10.1001/jama.2021.23487 · Cited by 302
Metadata
- Authors
- Workowski, K. A., Bachmann, L. H., Chan, P. A., Johnston, C. M., Muzny, C. A., Park, I., Reno, H., Zenilman, J. M., & Bolan, G. A.
- Affiliations
- Emory University (US)
- National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention (US)
- Brown University (US)
- University of Washington (US)
- University of Alabama at Birmingham (US)
- Johns Hopkins University (US)
- Washington University in St. Louis (US)
- Corresponding author
- Workowski, Kimberly A.
- ORCID
- Venue
- MMWR. Recommendations and Reports
- Published
- 2021-07-23
- Volume
- 70
- Issue
- 4
- Pages
- 1-187
- ISSN
- 1057-5987 (ISSN-L)
- 1545-8601
- PMC
- PMC8344968
- OpenAlex
- W3185444663
- Semantic Scholar
- eb300ecb7d38078ce65557d8188da1edbd3174fc
- Cited by
- 3,018
- References
- 1,505
- Citations by year
- 2026: 740 · 2025: 655 · 2024: 606 · 2023: 558 · 2022: 385 · 2021: 64
- FWCI
- 256.76
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- public-domain
- Locations
- MMWR Recommendations and Reports (publishedVersion, public-domain)
- PubMed Central (publishedVersion, public-domain)
- PubMed (publishedVersion)
- Funders
- National Institute of Mental Health (R25MH083620)
- Topics
- Life Sciences › Immunology and Microbiology › Microbiology › Reproductive tract infections research
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
- Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
- Keywords
- sexually transmitted infections, STI treatment, gonorrhea, Chlamydia trachomatis, Trichomonas vaginalis, pelvic inflammatory disease, bacterial vaginosis, Mycoplasma genitalium, HPV vaccine, HCV screening, HIV prevention
- MeSH terms
- Centers for Disease Control and Prevention, U.S., Humans, Sexually Transmitted Diseases, United States
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
